Head and Neck Undifferentiated Carcinoma

Head and Neck Undifferentiated Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

67 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 13
Ph III recruiting: 2
Growth YoY: —
Industry share: 8%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04579757	Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors	terminated	Phase 1 / Phase 2	87	HutchmedINDUSTRY	1	May 8, 2025	clinicaltrials
NCT00603941	A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel	terminated	Phase 1 / Phase 2	19	Daiichi SankyoINDUSTRY	1	Sep 16, 2020	clinicaltrials